exagen-logo-440x386-1.jpg
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
30 mai 2023 09h00 HE | Exagen Inc.
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 43rd Annual Growth...
exagen-logo-440x386-1.jpg
Exagen Inc. Reports First Quarter 2023 Results
15 mai 2023 16h05 HE | Exagen Inc.
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN)("Exagen"), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31,...
exagen-logo-440x386-1.jpg
Exagen Announces Campaign for Lupus Awareness Month
01 mai 2023 16h05 HE | Exagen Inc.
SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a...
exagen-logo-440x386-1.jpg
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
24 avr. 2023 16h05 HE | Exagen Inc.
SAN DIEGO, April 24, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2023,...
exagen-logo-440x386-1.jpg
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
20 mars 2023 16h05 HE | Exagen Inc.
SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...
exagen-logo-440x386-1.jpg
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
06 mars 2023 16h05 HE | Exagen Inc.
SAN DIEGO, March 06, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December...
exagen-logo-440x386-1.jpg
Exagen Inc. to Participate in Upcoming March Conferences
27 févr. 2023 09h00 HE | Exagen Inc.
SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following March...
exagen-logo-440x386-1.jpg
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
30 janv. 2023 16h05 HE | Exagen Inc.
SAN DIEGO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health,...
exagen-logo-440x386-1.jpg
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
23 janv. 2023 09h00 HE | Exagen Inc.
SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive...
exagen-logo-440x386-1.jpg
Exagen Inc. Reports Third Quarter 2022 Results
14 nov. 2022 16h05 HE | Exagen Inc.
SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2022....